Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
Medical Review · 13.06.2025 · 5 (3) · 179-202
DOI: 10.1515/mr-2024-0064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Review, online erschienen am 23.12.2024. Verfasst von Xiaofeng Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Cen…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Beijing Municipal Administration of Hospitals' Ascent Plan, Beijing Brain Initiative from Beijing Municipal Science & Technology Commission, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder for which there are currently no effective treatment options. Increasing evidence suggests that AD is a systemic disease closely associated with the immune system, not merely a central nervous system (CNS) disorder. Immune cells play crucial roles in the onset and progression of AD. Microglia and astrocytes are the primary inflammatory cells in the brain that can sensitively detect changes in the internal environment and transform into different phenotypes to exert differing effects at various stages of AD. Peripheral immune cells, such as T cells, B cells, monocytes/macrophages, and neutrophils can also be recruited to the CNS to mediate the inflammatory response in AD. As such, investigating the role of immune cells in AD is particularly important for elucidating its specific pathogenesis. This review primarily discusses the roles of central innate immune cells, peripheral immune cells, and the interactions between central and peripheral immune cells in the development of neuroinflammation in AD. Furthermore, we listed clinical trials targeting AD-associated neuroinflammation, which may represent a promising direction for developing effective treatments for AD in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.
ORCID-Profile: Longfei Jia
Förderung
- the Beijing Municipal Administration of Hospitals' Ascent Plan
- Beijing Brain Initiative from Beijing Municipal Science & Technology Commission
- National Natural Science Foundation of China
- STI2030-Major Projects
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Fu, X., Cai, H., Quan, S., Ren, Z., Xu, Y., & Jia, L. (2025). Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets. Medical Review, 5(3), 179-202. https://doi.org/10.1515/mr-2024-0064
Vancouver
Fu X, Cai H, Quan S, Ren Z, Xu Y, Jia L. Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets. Medical Review. 2025;5(3):179-202. doi:10.1515/mr-2024-0064
BibTeX
@article{Fu2025,
author = {Fu, Xiaofeng and Cai, Huimin and Quan, Shuiyue and Ren, Ziye and Xu, Yinghao and Jia, Longfei},
title = {Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets},
journal = {Medical Review},
year = {2025},
volume = {5},
number = {3},
pages = {179--202},
doi = {10.1515/mr-2024-0064}
}
EUVIMED